Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yuzi Zhao, Jie Pi, Lihua Liu, Wenjie Yan, Shufang Ma & Li Hong. (2021) Identification of the Hub Genes Associated with the Prognosis of Ovarian Cancer Patients via Integrated Bioinformatics Analysis and Experimental Validation. Cancer Management and Research 13, pages 707-721.
Read now
Read now
Articles from other publishers (26)
Angelika V. Timofeeva, Ivan S. Fedorov, Aleksandra V. Asaturova, Maya V. Sannikova, Anna V. Tregubova, Oleg A. Mayboroda, Grigory N. Khabas, Vladimir E. Frankevich & Gennady T. Sukhikh. (2023) Blood Plasma Small Non-Coding RNAs as Diagnostic Molecules for the Progesterone-Receptor-Negative Phenotype of Serous Ovarian Tumors. International Journal of Molecular Sciences 24:15, pages 12214.
Crossref
Crossref
Quanxiao Xu, Xianzhe Li, Yan Li, Jinsong Yu & Aimin Yang. (2023) Kinesin family member 23 knockdown inhibits cell proliferation and epithelial-mesenchymal transition in esophageal carcinoma by inactivating the Wnt/β-catenin pathway. Functional & Integrative Genomics 23:2.
Crossref
Crossref
Hongbo Xu, Jingjing Liu, Yajun Zhang, Yan Zhou, Lei Zhang, Jia Kang, Can Ning, Zelai He & Shilong Song. (2023) KIF23, under regulation by androgen receptor, contributes to nasopharyngeal carcinoma deterioration by activating the Wnt/β-catenin signaling pathway. Functional & Integrative Genomics 23:2.
Crossref
Crossref
Xiaojuan Su, Binbin Wang, Bo Zhang & Shiwen Pan. (2023) MiR-588 acts as an oncogene in ovarian cancer and increases the radioresistance of ovarian cancer cells. Journal of Radiation Research 64:3, pages 558-568.
Crossref
Crossref
Wenting Tang, Li Zhang, Jing Li & Yu Guan. (2023) KCNQ1OT1 promotes retinoblastoma progression by targeting miR-339-3p that suppresses KIF23. International Ophthalmology 43:7, pages 2419-2432.
Crossref
Crossref
Bing Li, Ge Lou, Jiahui Zhang, Ning Cao & Xi Yu. (2022) Repression of lncRNA PART1 attenuates ovarian cancer cell viability, migration and invasion through the miR-503-5p/FOXK1 axis. BMC Cancer 22:1.
Crossref
Crossref
Amoolya Kandettu, Divya Adiga, Vasudha Devi, Padmanaban S. Suresh, Sanjiban Chakrabarty, Raghu Radhakrishnan & Shama Prasada Kabekkodu. (2022) Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine. Genes & Diseases 9:6, pages 1443-1465.
Crossref
Crossref
Jiaxin Liu, Yimin Li, Qing Xiao, Yuanyuan Li, Yuqian Peng, Yaqi Gan, Guang Shu, Hanxi Yi & Gang Yin. (2022) Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer. BMC Cancer 22:1.
Crossref
Crossref
Zonglong Wu, Yimeng Song, Yaqian Wu, Liyuan Ge, Zhuo Liu, Tan Du, Shudong Zhang & Lulin Ma. (2022) Identification of KIF23 as a Prognostic Biomarker Associated With Progression of Clear Cell Renal Cell Carcinoma. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Jiangying Xuan, Yingxia Liu, Xiaoping Zeng & Hongmei Wang. (2022) Sequence Requirements for miR-424-5p Regulating and Function in Cancers. International Journal of Molecular Sciences 23:7, pages 4037.
Crossref
Crossref
Hong‐Cheng Lv, Yan‐Yan Lv, Gang Wang, Xie‐Hua Zhang, Sheng‐Nan Li, Xiao‐Fen Yue & Wei Lu. (2022)
Mechanism of
miR
‐424‐5p promoter methylation in promoting epithelial–mesenchymal transition of hepatocellular carcinoma cells
. The Kaohsiung Journal of Medical Sciences 38:4, pages 336-346.
Crossref
Crossref
Yonghong Sun, Haixia Pan, Yanwei He, Chunmei Hu & Yi Gu. (2021)
Functional roles of the
SHCBP1
and
KIF23
interaction in modulating the cell‐cycle and cisplatin resistance of head and neck squamous cell carcinoma
. Head & Neck 44:3, pages 591-605.
Crossref
Crossref
Ruth Rodríguez‐Barrueco, Jessica Latorre, Laura Devis‐Jáuregui, Aina Lluch, Nuria Bonifaci, Francisco J. Llobet, Mireia Olivan, Laura Coll‐Iglesias, Katja Gassner, Meredith L. Davis, José M. Moreno‐Navarrete, Anna Castells‐Nobau, Laura Plata‐Peña, Miki Dalmau‐Pastor, Marcus Höring, Gerhard Liebisch, Vesa M. Olkkonen, Maria Arnoriaga‐Rodríguez, Wifredo Ricart, José M. Fernández‐Real, José M. Silva, Francisco J. Ortega & David Llobet‐Navas. (2021) A microRNA Cluster Controls Fat Cell Differentiation and Adipose Tissue Expansion By Regulating SNCG. Advanced Science 9:4.
Crossref
Crossref
Wende Hao, Hongyu Zhao, Zhefeng Li, Jie Li, Jiahao Guo, Qi Chen, Yan Gao, Meng Ren, Xiaoting Zhao & Wentao Yue. (2021) Identification of potential markers for differentiating epithelial ovarian cancer from ovarian low malignant potential tumors through integrated bioinformatics analysis. Journal of Ovarian Research 14:1.
Crossref
Crossref
Ping Li, Hongyan Xin & Lili Lu. (2021) Extracellular vesicle-encapsulated microRNA-424 exerts inhibitory function in ovarian cancer by targeting MYB. Journal of Translational Medicine 19:1.
Crossref
Crossref
Thomas J. Kalantzakos, Travis B. Sullivan, Thales Gloria, David Canes, Alireza Moinzadeh & Kimberly M. Rieger-Christ. (2021) MiRNA-424-5p Suppresses Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma and Attenuates Expression of O-GlcNAc-Transferase. Cancers 13:20, pages 5160.
Crossref
Crossref
Min Zhou, Shasha Hong, Bingshu Li, Cheng Liu, Ming Hu, Jie Min, Jianming Tang & Li Hong. (2021) Development and Validation of a Prognostic Nomogram Based on DNA Methylation-Driven Genes for Patients With Ovarian Cancer. Frontiers in Genetics 12.
Crossref
Crossref
Ning Xu, Ru-Nan Dong, Ting-Ting Lin, Tian Lin, Yun-Zhi Lin, Shao-Hao Chen, Jun-Ming Zhu, Zhi-Bin Ke, Fei Huang, Ye-Hui Chen & Xue-Yi Xue. (2021) Development and Validation of Novel Biomarkers Related to M2 Macrophages Infiltration by Weighted Gene Co-Expression Network Analysis in Prostate Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Arkadiusz Gajek, Patrycja Gralewska, Agnieszka Marczak & Aneta Rogalska. (2021) Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer. Cancers 13:11, pages 2690.
Crossref
Crossref
Zheng Zhao, Zheng Wang, Zhao-Shi Bao, Wei-Zhen Gao, Yuan-Da Zhang, Ci-Jie Ruan, Tao Lv, Yong Wang & Li-Hua Sun. (2021) Mutation and Copy Number Alterations Analysis of KIF23 in Glioma. Frontiers in Genetics 12.
Crossref
Crossref
Karolina Seborova, Radka Vaclavikova, Lukas Rob, Pavel Soucek & Pavel Vodicka. (2021) Non-Coding RNAs as Biomarkers of Tumor Progression and Metastatic Spread in Epithelial Ovarian Cancer. Cancers 13:8, pages 1839.
Crossref
Crossref
Jana Gregorova, Petra Vychytilova-Faltejskova & Sabina Sevcikova. (2021) Epigenetic Regulation of MicroRNA Clusters and Families during Tumor Development. Cancers 13:6, pages 1333.
Crossref
Crossref
Ye Wu, Wei Wang, An-Gang Yang & Rui Zhang. (2020) The microRNA-424/503 cluster: A master regulator of tumorigenesis and tumor progression with paradoxical roles in cancer. Cancer Letters 494, pages 58-72.
Crossref
Crossref
Yimin Li, Jiaxin Liu, Qing Xiao, Ruotong Tian, Zhengwei Zhou, Yaqi Gan, Yuanyuan Li, Guang Shu & Gang Yin. (2020) EN2 as an oncogene promotes tumor progression via regulating CCL20 in colorectal cancer. Cell Death & Disease 11:7.
Crossref
Crossref
Hongkai Zhuang, Zuyi Ma, Kaijun Huang, Zixuan Zhou, Bowen Huang, Zhonghai Sun, Baohua Hou & Chuanzhao Zhang. (2020) Establishment of a 7-miRNA–Based Risk Score System for Predicting Prognosis of Pancreatic Cancer. Pancreas 49:5, pages 655-662.
Crossref
Crossref
Hanna Engqvist, Toshima Z. Parris, Anikó Kovács, Elisabeth Werner Rönnerman, Karin Sundfeldt, Per Karlsson & Khalil Helou. (2020) Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry. Frontiers in Oncology 10.
Crossref
Crossref